Hims & Hers Health (NYSE: HIMS) CFO sells 7,163 shares after exercising options
Rhea-AI Filing Summary
Hims & Hers Health CFO Oluyemi Okupe exercised stock options for 7,163 Class A shares at $5.0100 on July 17, 2026, then sold 7,163 shares at a weighted-average price of $31.9933 under a Rule 10b5-1 plan adopted May 21, 2025. After these transactions he holds 284,321 Class A shares directly, 7,853 shares indirectly through a separate property trust, and 95,198 stock options remaining.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,163 shares ($193K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Okupe Oluyemi
Role
Chief Financial Officer
Sold
7,163 shs ($229K)
Approx. gross sale proceeds
$229K
Approx. exercise cost
$36K
Approx. pre-tax spread
$193K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F1, F3 | 7,163 | $0.00 | -- |
| Exercise | Class A Common Stock F1 | 7,163 | $5.01 | $36K |
| Sale | Class A Common Stock F1, F2 | 7,163 | $31.9933 | $229K |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 95,198 shares (Direct);
Class A Common Stock — 284,321 shares (Direct);
Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)
Footnotes (3)
- F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Key Figures
Shares sold: 7,163 shares of Class A Common Stock
Weighted-average sale price: $31.9933 per share
Options exercised: 7,163 stock options
+4 more
7 metrics
Shares sold
7,163 shares of Class A Common Stock
Shares sold on 2026-07-17 in open-market or private transactions
Weighted-average sale price
$31.9933 per share
Average price for 7,163 shares sold on 2026-07-17; trades ranged $31.93–$32.06
Options exercised
7,163 stock options
Options exercised into Class A Common Stock at $5.0100 per share on 2026-07-17
Exercise price
$5.0100 per share
Conversion or exercise price of Stock Option (right to buy) into Class A Common Stock
Direct shares after transactions
284,321 shares
Class A Common Stock directly owned by CFO following July 17, 2026 trades
Indirect shares via trust
7,853 shares
Class A Common Stock held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Stock options remaining
95,198 options
Stock Option (right to buy) balance after 7,163 options exercised on 2026-07-17; expires 2032-02-23
Key Terms
Rule 10b5-1 trading plan, average weighted price, Vesting Commencement Date, Stock Option (right to buy), +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The stock option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
average weighted price financial
"Price reported constitutes the average weighted price of shares sold."
Vesting Commencement Date financial
"anniversary of the Vesting Commencement Date of January 24, 2022."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Stock Option (right to buy) financial
"Transaction reported in a Stock Option (right to buy) derivative security."
Separate Property Trust financial
"Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider trades did Hims & Hers Health (HIMS) CFO Oluyemi Okupe report on July 17, 2026?
CFO Oluyemi Okupe exercised 7,163 stock options at $5.0100 and then sold 7,163 Class A shares at a weighted-average price of $31.9933, all executed on July 17, 2026 under a pre-arranged Rule 10b5-1 trading plan.
Were the Hims & Hers Health (HIMS) insider trades by CFO Okupe under a Rule 10b5-1 plan?
Yes. A footnote states the stock option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025, indicating the trades followed a pre-arranged schedule rather than discretionary market timing.
What stock option balance remains for Hims & Hers Health (HIMS) CFO Okupe after the July 2026 exercise?
Following the July 17, 2026 option exercise of 7,163 units, CFO Oluyemi Okupe has 95,198 Stock Option (right to buy) units remaining, with these options relating to Class A Common Stock and carrying an expiration date of February 23, 2032.
What is the vesting schedule of the Hims & Hers Health (HIMS) options involved in CFO Okupe’s trades?
A footnote explains that 25% of the options vest on the 12-month anniversary of the Vesting Commencement Date of January 24, 2022. The remaining 75% vest in 36 equal monthly installments thereafter, subject to continuous service.